Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RGS16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SPEF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928623 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
AFMID - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRA2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP2R2D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANXA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLJ21408 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C16orf54 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF396 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OARD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EML4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM135 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IDS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYNPO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPG5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on